Novo Nordisk
Rebekka Dam-Tuxen is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as Vice President Project and Director of Site Support and Improvements in Diabetes Finished Products Manufacturing Development at Novo Nordisk since February 2014. Prior experience includes various leadership roles at Kopenhagen Fur from May 2010 to January 2014, including Project Manager at Kopenhagen Diagnostics, focusing on automation solutions. Rebekka's academic background includes a PhD in Immunology and Molecular Biology from the University of Copenhagen, complemented by postdoctoral research at the Technical University of Denmark and a research assistantship at the Faculty of Pharmaceutical Sciences, University of Copenhagen. Rebekka is also currently pursuing Six Sigma black belt training to enhance operational efficiency.
Novo Nordisk
377 followers
Novo Nordisk is a global healthcare company with 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases.